DNLI
$17.61-3.98%
Denali Therapeutics Inc.Stock · HealthcareRussell 2000 0.1%Nasdaq Composite 0.01%Russell 3000 0.005%US Stock Market 0.005%
Denali Therapeutics Inc. monthly returns
Denali Therapeutics Inc. has averaged 1.68% per month, positive in 49% of months. Month-by-month returns for Denali Therapeutics Inc. (DNLI) below, through October 16, 2026 — the table lists the most recent months; the bar chart plots the last 5 years.
Average month
+1.7%
106 months
Best month
+55.9%
Aug 2018
Worst month
-34.9%
Jul 2021
Positive months
49%
of all months
Denali Therapeutics Inc. monthly returns#
| Month | Path | Total return |
|---|---|---|
| Oct 2026 | -14.8% | |
| Sep 2026 | -13.0% | |
| Aug 2026 | +3.2% | |
| Jul 2026 | -10.5% | |
| Jun 2026 | +22.2% | |
| May 2026 | +12.4% | |
| Apr 2026 | -2.5% | |
| Mar 2026 | -9.3% | |
| Feb 2026 | -2.6% | |
| Jan 2026 | +31.7% | |
| Dec 2025 | -15.2% | |
| Nov 2025 | +19.6% | |
| Oct 2025 | +12.1% | |
| Sep 2025 | -4.9% | |
| Aug 2025 | +10.4% | |
| Jul 2025 | -1.1% | |
| Jun 2025 | +5.7% | |
| May 2025 | -20.5% | |
| Apr 2025 | +22.5% | |
| Mar 2025 | -17.9% | |
| Feb 2025 | -28.9% | |
| Jan 2025 | +14.3% | |
| Dec 2024 | -18.5% | |
| Nov 2024 | -3.7% | |
| Oct 2024 | -10.9% | |
| Sep 2024 | +19.2% | |
| Aug 2024 | +0.3% | |
| Jul 2024 | +5.0% | |
| Jun 2024 | +25.1% | |
| May 2024 | +20.2% | |
| Apr 2024 | -24.8% | |
| Mar 2024 | +3.7% | |
| Feb 2024 | +23.5% | |
| Jan 2024 | -25.4% | |
| Dec 2023 | +15.9% | |
| Nov 2023 | -1.6% | |
| Oct 2023 | -8.7% | |
| Sep 2023 | -10.7% | |
| Aug 2023 | -18.8% | |
| Jul 2023 | -3.7% | |
| Jun 2023 | -2.3% | |
| May 2023 | +21.7% | |
| Apr 2023 | +7.8% | |
| Mar 2023 | -15.1% | |
| Feb 2023 | -10.3% | |
| Jan 2023 | +8.8% | |
| Dec 2022 | -12.8% | |
| Nov 2022 | +11.3% | |
| Oct 2022 | -6.5% | |
| Sep 2022 | +10.9% | |
| Aug 2022 | -18.7% | |
| Jul 2022 | +15.6% | |
| Jun 2022 | +21.2% | |
| May 2022 | +2.1% | |
| Apr 2022 | -26.0% | |
| Mar 2022 | -1.2% | |
| Feb 2022 | -4.9% | |
| Jan 2022 | -23.3% | |
| Dec 2021 | -3.6% | |
| Nov 2021 | -4.3% | |
| Oct 2021 | -4.2% | |
| Sep 2021 | -5.2% | |
| Aug 2021 | +4.3% | |
| Jul 2021 | -34.9% | |
| Jun 2021 | +23.4% | |
| May 2021 | +5.2% | |
| Apr 2021 | +5.8% | |
| Mar 2021 | -20.5% | |
| Feb 2021 | +4.8% | |
| Jan 2021 | -18.2% | |
| Dec 2020 | +37.4% | |
| Nov 2020 | +42.5% | |
| Oct 2020 | +19.4% | |
| Sep 2020 | +12.3% | |
| Aug 2020 | +36.2% | |
| Jul 2020 | -3.1% | |
| Jun 2020 | -13.1% | |
| May 2020 | +27.3% | |
| Apr 2020 | +24.8% | |
| Mar 2020 | -11.4% | |
| Feb 2020 | -14.6% | |
| Jan 2020 | +33.0% | |
| Dec 2019 | -2.1% | |
| Nov 2019 | +13.5% | |
| Oct 2019 | +2.3% | |
| Sep 2019 | -14.9% | |
| Aug 2019 | -15.7% | |
| Jul 2019 | +2.8% | |
| Jun 2019 | +8.9% | |
| May 2019 | -22.1% | |
| Apr 2019 | +5.4% | |
| Mar 2019 | +6.7% | |
| Feb 2019 | +14.2% | |
| Jan 2019 | -7.7% | |
| Dec 2018 | +7.8% | |
| Nov 2018 | +32.5% | |
| Oct 2018 | -33.4% | |
| Sep 2018 | +10.7% | |
| Aug 2018 | +55.9% | |
| Jul 2018 | -17.4% | |
| Jun 2018 | -20.7% | |
| May 2018 | +4.1% | |
| Apr 2018 | -6.1% | |
| Mar 2018 | -14.0% | |
| Feb 2018 | -1.6% | |
| Jan 2018 | +48.7% |
Monthly total return (since Nov 2021)#
-30%-20%-10%0%10%20%30%
Nov 2021-4.3%
Dec 2021-3.6%
Jan 2022-23%2022
Feb 2022-4.9%
Mar 2022-1.2%
Apr 2022-26%
May 2022+2.1%
Jun 2022+21%
Jul 2022+16%
Aug 2022-19%
Sep 2022+11%
Oct 2022-6.5%
Nov 2022+11%
Dec 2022-13%
Jan 2023+8.8%2023
Feb 2023-10%
Mar 2023-15%
Apr 2023+7.8%
May 2023+22%
Jun 2023-2.3%
Jul 2023-3.7%
Aug 2023-19%
Sep 2023-11%
Oct 2023-8.7%
Nov 2023-1.6%
Dec 2023+16%
Jan 2024-25%2024
Feb 2024+24%
Mar 2024+3.7%
Apr 2024-25%
May 2024+20%
Jun 2024+25%
Jul 2024+5.0%
Aug 2024+0.29%
Sep 2024+19%
Oct 2024-11%
Nov 2024-3.7%
Dec 2024-18%
Jan 2025+14%2025
Feb 2025-29%
Mar 2025-18%
Apr 2025+22%
May 2025-20%
Jun 2025+5.7%
Jul 2025-1.1%
Aug 2025+10%
Sep 2025-4.9%
Oct 2025+12%
Nov 2025+20%
Dec 2025-15%
Jan 2026+32%2026
Feb 2026-2.6%
Mar 2026-9.3%
Apr 2026-2.5%
May 2026+12%
Jun 2026+22%
Jul 2026-10%
Aug 2026+3.2%
Sep 2026-13%
Oct 2026-15%
Denali Therapeutics Inc. returns by calendar month#
Every month of every year since 2018, one tick per year on a shared scale; the dark bar is the month's average. Total returns, dividends reinvested.
October 2026 so far: -14.80% — 8th of 9 Octobers since 2018 at the last close; the average October returned -3.7%.
| Month | −60%0+60% | Average | Median | Up | Best | Worst |
|---|---|---|---|---|---|---|
| Jan | +6.9% | +8.8% | 56% | +48.7% 2018 | -25.4% 2024 | |
| Feb | -2.3% | -2.6% | 33% | +23.5% 2024 | -28.9% 2025 | |
| Mar | -8.8% | -11.4% | 22% | +6.7% 2019 | -20.5% 2021 | |
| Apr | +0.8% | +5.4% | 56% | +24.8% 2020 | -26.0% 2022 | |
| May | +5.6% | +5.2% | 78% | +27.3% 2020 | -22.1% 2019 | |
| Jun | +7.8% | +8.9% | 67% | +25.1% 2024 | -20.7% 2018 | |
| Jul | -5.3% | -3.1% | 33% | +15.6% 2022 | -34.9% 2021 | |
| Aug | +6.4% | +3.2% | 67% | +55.9% 2018 | -18.8% 2023 | |
| Sep | +0.5% | -4.9% | 44% | +19.2% 2024 | -14.9% 2019 | |
| Oct | -3.7% | -5.4% | 38% | +19.4% 2020 | -33.4% 2018 | |
| Nov | +13.7% | +12.4% | 63% | +42.5% 2020 | -4.3% 2021 | |
| Dec | +1.1% | -2.8% | 38% | +37.4% 2020 | -18.5% 2024 |
Methodology#
Monthly returns are total returns (dividends reinvested), computed from DNLI's split- and dividend-adjusted month-end closes. The table shows the most recent 120 months and the bar chart the most recent 60. See the year-by-year returns for the annual view. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Denali Therapeutics Inc.'s average monthly return?
- Denali Therapeutics Inc. (DNLI) has averaged about 1.68% per month, positive in roughly 49% of months. The best month was Aug 2018 (+55.9%) and the worst was Jul 2021 (-34.9%).
More on Denali Therapeutics Inc.
By month for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100